Are you the best at what you do?
Designed to assess and reward the competencies and potential of pharma marketers and teams, the PharmaTimes Marketer of the Year competition identifies and benchmarks marketing talent within pharma organisations.
Read on PharmaTimes
Can you deliver the results you need to take your customer’s business to the next level?
If the answer is yes, why not show us and everyone else how it's done by entering PharmaTimes Communications Team of the Year Awards TODAY!
Read on PharmaTimes
Early access to Santhera’s DMD therapy Raxone extended in the UK
UK regulators have renewed the scientific opinion for Santhera’s Raxone, extending its availability to patients with Duchenne muscular dystrophy (DMD) through the Early Access to Medicines Scheme (EAMS) for another year.
Read on PharmaTimes
BMS files Opdivo/Yervoy combo for lung cancer
US regulators have accepted Bristol-Myers Squibb’s application to market its immunotherapy Opdivo plus Yervoy for the treatment of first-line advanced non-small cell lung cancer (NSCLC) in certain patients.
Read on PharmaTimes
Sanofi’s Dupixent approved for routine NHS use
Adults with moderate to severe atopic dermatitis are a step closer to being able to routinely access treatment with Sanofi’s Dupixent on the NHS, following a green light from cost regulators.
Read on PharmaTimes
1
2
3
Next
